Catalyst Wire Dossier Catalyst Wire Dossier

Alvocidib (Flavopiridol)

alvocidib
Drug timelines are a Plus or Pro feature.

1 regulatory and trial event tracked for Alvocidib (Flavopiridol), covering 2015-04-02 to 2015-04-02. Get the full timeline:

Most recent: Clinical Trial Update: Lenalidomide and Alvocidib in Treating Patients With Relapsed or Refractory B-cell Chronic Lymphocytic Leukemia or Small Lymphocytic Lymphoma [Phase 1]

See pricing